Mini Review
Accepted on 12 Feb 2026
Metal-based compounds and Chagas Disease treatment: current knowledge and therapeutic perspectives
in Anti-Infective Agents
Frontiers in Drug Discovery
Type at least 3 characters
156 articles
articles
Mini Review
Published on 11 Feb 2026
Standardization of canine infections for the development of antileishmanial drugs
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2026.1754269
- 297 views
Specialty Grand Challenge
Accepted on 04 Feb 2026
Revisiting the Grand Challenges: The Road Travelled and Ahead at the Frontiers of Computer-Aided Drug Design
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
- 181 views
Brief Research Report
Published on 28 Jan 2026
Structure-based virtual screening for TRPM8 modulators
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2026.1770904
- 646 views
Original Research
Published on 16 Jan 2026
Enhancing structure-based virtual screening of MDM2–p53 inhibitors: a benchmark of machine learning vs. traditional docking scoring functions
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1731262
- 1,364 views
Brief Research Report
Published on 05 Jan 2026
Dual RNA polymerase I inhibition with CX-5461 and BMH-21 synergizes in breast cancer by activating p53-dependent stress
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1677461
- 911 views
Specialty Grand Challenge
Published on 05 Jan 2026
Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
in Dermatologic Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1752852
- 1,257 views
Original Research
Accepted on 26 Dec 2025
Across pre-clinical and clinical platforms, approved and investigational psychiatric drugs share pathways and associate with similar molecular functions
in Technologies and Strategies to Enable Drug Discovery
Frontiers in Drug Discovery
- 595 views
Review
Published on 10 Dec 2025
Exploring deep learning approaches in anticancer drug design: a review of recent advances
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1713308
- 1,713 views
Original Research
Published on 10 Dec 2025
A network-based protocol to prioritize compounds for biological testing: discovery of Anti-Staphylococcus aureus cacalol derivatives
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1724392
- 1,032 views
Original Research
Accepted on 09 Dec 2025
Multivalent display of membrane proteins using HIV1-Gag VLPs
in Technologies and Strategies to Enable Drug Discovery
Frontiers in Drug Discovery
- 335 views
Study Protocol
Published on 09 Dec 2025
Integrated in vivo and in silico evaluation of antimalarial compounds from Vernonia ambigua leaves identified by GC-MS profiling
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1635697
- 943 views
Original Research
Published on 10 Nov 2025
Towards human cardiac new approach methodologies (NAMs) to evaluate the combination of repolarization prolonging and shortening drugs: a pilot study
in Cardiovascular and Hematologic Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1679626
- 1,695 views
- 3 citations
Original Research
Published on 17 Sep 2025
Influence of divalent metal ions on gelation of a short heterochiral peptide
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1673051
- 1,397 views
Original Research
Published on 10 Sep 2025
Bioinformatics-driven identification and prioritization of PTSD targets based on published multi-omic data
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1613261
- 2,061 views
Perspective
Published on 03 Sep 2025
Advancing histone deacetylase 6 (HDAC6) as a promising therapeutic target for Alzheimer’s disease: from molecular insights to clinical prospects
in Neurological Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1662691
- 4,297 views
- 1 citation
Opinion
Published on 25 Aug 2025
On the biologically relevant chemical space: BioReCS
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1674289
- 3,752 views
- 3 citations
Mini Review
Published on 26 Jun 2025
AI-driven innovation in antibody-drug conjugate design
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1628789
- 10,994 views
- 8 citations
Editorial
Published on 10 Jun 2025
Editorial: Pharmacokinetics modeling in the Artificial Intelligence Era
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1636070
- 2,203 views
- 1 citation
Original Research
Published on 06 Jun 2025
Dual upregulation of miRNA-143 and miRNA-506 in non-small cell lung cancer inhibits proliferation, motility, migration, and tumor growth
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1584801
- 2,431 views
Editorial
Published on 04 Jun 2025
Editorial: Enhancing drug discovery through structure-based design and computational techniques
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1632015
- 2,343 views
Original Research
Published on 30 May 2025
Safety and tolerability of a bevacizumab biosimilar (Effivia®) in adult Mexican patients with cancer: a multicenter, observational, prospective clinical study
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1591991
- 1,934 views
Original Research
Published on 15 Apr 2025
Identification of natural compounds as potential inhibitors of Interleukin-23: virtual screening, ADMET, drug-likeness, and dynamic simulation
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1525533
- 3,530 views
- 10 citations
Original Research
Published on 21 Feb 2025
Transduction of hematopoietic stem and progenitor cells by an MECP2 lentiviral vector improves Rett syndrome phenotypes
in Neurological Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1545391
- 2,625 views